ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report from the American Association for Vascular Surgery/Society for Vascular Surgery,⁎Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients

Hirsch, Alan T.; Haskal, Ziv J.; Hertzer, Norman; Bakal, Curtis W.; Creager, Mark A.; Murphy, William R.; Olin, Jeffrey W.; Puschett, Jules B.; Rosenfield, Kenneth; Sacks, David; Stanley, James C.; Taylor, Lloyd M.; White, Christopher J.; White, John V.; White, Rodney A.; Antman, Elliott M.; Smith, Sidney C.; Adams, Cynthia D.; Anderson, Jeffrey L.; Faxon, David P.; Fuster, Valentı́n; Gibbons, Raymond J.; Halperin, Jonathan L.; Hiratzka, Loren F.; Hunt, Sharon A.; Jacobs, Alice K.; Nishimura, Rick A.; Ornato, Joseph P.; Page, Richard L.; Riegel, Bárbara

doi:10.1016/j.jacc.2006.02.024

Cited by 1,284 publications

(2,393 citation statements)

References 1,193 publications

(507 reference statements)

Supporting

Mentioning

2,201

Contrasting

Unclassified

161

Order By: Relevance

“…1 In particular, PAD is a strong predictor of subsequent cardiovascular morbidity and mortality as a result of concomitant coronary artery and cerebrovascular disease. 1,2 Patients with PAD have a threefold higher risk of myocardial infarction, stroke and death than those without PAD. 3 As a consequence of the Western lifestyle, the prevalence of PAD is high in industrialized countries.…”

Section: Introductionmentioning

confidence: 99%

“…6 Diabetes mellitus also increases the risk of PAD by 2-to 4-fold and is present in 12-20% of PAD patients. 2,7 Based on several epidemiological studies, the total prevalence is estimated at between 3 and 10% 5 of the general adult population, increasing with age to 15-20% in those older than 65. 5,8,9 Thus, assessing the ankle-brachial index (ABI) in all subjects older than 70 years, or in diabetics or smokers older than 50 years yields a positive result in B30% of subjects.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Automated oscillometric determination of the ankle-brachial index: a systematic review and meta-analysis

2012

View full text Add to dashboard Cite

Measurement of the ankle-brachial index (ABI) using a Doppler device is widely used to identify subjects with peripheral artery disease (PAD), and those who are at high risk of cardiovascular disease. This paper presents a systematic review (Medline/ PubMed, Embase and Cochrane) and meta-analysis of studies assessing the usefulness of automated oscillometric devices for ABI estimation and PAD detection compared with the conventional Doppler method. A total of 25 studies including 4186 subjects were analyzed. A random-effects model analysis showed that the average oscillometric ABI was similar to the Doppler ABI (mean difference ± s.e. 0.020 ± 0.018, P ¼ 0.3) but that the absolute differences were significant (0.048 ± 0.009, Po0.01). The pooled correlation coefficient (r) between the oscillometric and Doppler ABI was 0.71 ± 0.05. Simultaneous arm-leg measurements resulted in a smaller difference between the average oscillometric ABI value and the average Doppler ABI value than did sequential measurements ( À0.012 ± 0.022 vs. 0.040 ± 0.026, respectively, Po0.01). The average sensitivity and specificity of the oscillometric ABI estimation in PAD diagnosis was 69 ± 6% and 96 ± 1%, respectively (with Doppler ABI taken as the reference). These data suggest that an automated ABI measurement obtained by oscillometric blood pressure monitors is a reliable and practical alternative to the conventional Doppler measurement for the detection of PAD.To increase the sensitivity of the PAD diagnosis based on an oscillometric ABI, a higher threshold of 1.0 might be preferable.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Automated oscillometric determination of the ankle-brachial index: a systematic review and meta-analysis

2012

View full text Add to dashboard Cite

show abstract

“…We consecutively considered and analyzed the hospital discharge information of all patients hospitalized between March 1, 2007 [2][3][4][18][19][20]. This study allowed us to observe our steady-state situation of drug prescription, since it was performed without previous information campaign.…”

Section: Study Protocolmentioning

confidence: 99%

“…We then calculated the global prescription rate of secondary prophylaxis (number of prescribed medications divided by the number of indicated medications) and the proportion of patients who were prescribed the complete set of necessary medications (patients lacking one or more required prophylactic drug were defined as incompletely treated). The prescription of certain drugs was dependent on cut-off levels (lipid-lowering therapy, arterial hypertension) or the presence of diabetes mellitus (defined according to WHO-criteria) [2][3][4][18][19][20]24]. Neglected measurement of lipid levels during hospital stay accounted as non-adherence as well as co-existent diabetes mellitus and/or arterial hypertension without a corresponding therapy (lifestyle changes and/or pharmacotherapy) or without an explicit suggestion for appropriate follow up.…”

Section: Study Protocolmentioning

confidence: 99%

“…As vascular diseases share common risk factors and pathomechanisms, comparable guidelines have been published for peripheral arterial (PAD) and ischemic cerebrovascular (CVD) disease [17][18][19][20]. However, studies testing adherence to these recommendations have been performed very rarely for PAD and CVD [21], and this minor attention might hide a reduced adherence to guidelines [11,13,22].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Comparison of in-hospital secondary prevention for different vascular diseases

Perren

Cerutti

Lazzaro

et al. 2009

European Journal of Internal Medicine

View full text Add to dashboard Cite

Background: Secondary prevention of coronary artery disease is highly effective and implemented on a large scale. However, studies testing adherence to recommended secondary prevention of other vascular diseases are rare. Our goal was to evaluate whether the kind of vascular disease influences prescription practice of secondary drug prophylaxis at hospital discharge and to which extent secondary prevention is actually complete. Methods: A 3-month prospective observational review of the hospital discharge information of all patients hospitalized because of a vascular disease diagnosis: coronary artery disease (i. 3) for CVD. The proportion of patients who were prescribed a complete bundle of recommended medications was globally 29.5% (24.1-35.0). Conclusions: We found similar global prescription rates of secondary prevention for the different vascular diseases. However, only one third of the studied collective gets a complete set of required prophylactic drugs.

show abstract

Screening for Abdominal Aortic Aneurysm

Force

Owens

Davidson

et al. 2019

JAMA

186

View full text Add to dashboard Cite

IMPORTANCE An abdominal aortic aneurysm (AAA) is typically defined as aortic enlargement with a diameter of 3.0 cm or larger. The prevalence of AAA has declined over the past 2 decades among screened men 65 years or older in various European countries. The current prevalence of AAA in the United States is unclear because of the low uptake of screening. Most AAAs are asymptomatic until they rupture. Although the risk for rupture varies greatly by aneurysm size, the associated risk for death with rupture is as high as 81%.OBJECTIVE To update its 2014 recommendation, the USPSTF commissioned a review of the evidence on the effectiveness of 1-time and repeated screening for AAA, the associated harms of screening, and the benefits and harms of available treatments for small AAAs (3.0-5.4 cm in diameter) identified through screening.POPULATION This recommendation applies to asymptomatic adults 50 years or older. However, the randomized trial evidence focuses almost entirely on men aged 65 to 75 years.EVIDENCE ASSESSMENT Based on a review of the evidence, the USPSTF concludes with moderate certainty that screening for AAA in men aged 65 to 75 years who have ever smoked is of moderate net benefit. The USPSTF concludes with moderate certainty that screening for AAA in men aged 65 to 75 years who have never smoked is of small net benefit. The USPSTF concludes that the evidence is insufficient to determine the net benefit of screening for AAA in women aged 65 to 75 years who have ever smoked or have a family history of AAA. The USPSTF concludes with moderate certainty that the harms of screening for AAA in women aged 65 to 75 years who have never smoked and have no family history of AAA outweigh the benefits.RECOMMENDATIONS The USPSTF recommends 1-time screening for AAA with ultrasonography in men aged 65 to 75 years who have ever smoked. (B recommendation) The USPSTF recommends that clinicians selectively offer screening for AAA with ultrasonography in men aged 65 to 75 years who have never smoked rather than routinely screening all men in this group. (C recommendation) The USPSTF recommends against routine screening for AAA with ultrasonography in women who have never smoked and have no family history of AAA. (D recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for AAA with ultrasonography in women aged 65 to 75 years who have ever smoked or have a family history of AAA. (I statement)

show abstract

Cited by 1,284 publications

References 1,193 publications

Automated oscillometric determination of the ankle-brachial index: a systematic review and meta-analysis

Automated oscillometric determination of the ankle-brachial index: a systematic review and meta-analysis

Comparison of in-hospital secondary prevention for different vascular diseases

Screening for Abdominal Aortic Aneurysm

Contact Info

Product

Resources

About